Literature DB >> 3738468

Bowel adenocarcinoma in a patient with cystic fibrosis.

J A Roberts, W M Tullett, J S Thomas, D Galloway, B H Stack.   

Abstract

Cystic fibrosis (CF) is an autosomal recessive condition affecting one in 2,000 live births in the UK. There are few reports of malignant tumours in this condition probably because, until recently, the majority died before the age of 30 years as a result of recurrent and chronic bronchopulmonary infection with impaired growth and development and resistance to infection due to pancreatic malabsorption. We describe an adult male with CF who died from an adenocarcinoma affecting the ileocaecal region of the bowel.

Entities:  

Mesh:

Year:  1986        PMID: 3738468     DOI: 10.1177/003693308603100210

Source DB:  PubMed          Journal:  Scott Med J        ISSN: 0036-9330            Impact factor:   0.729


  6 in total

Review 1.  Gastrointestinal complications in cystic fibrosis.

Authors:  J M Littlewood
Journal:  J R Soc Med       Date:  1992       Impact factor: 5.344

2.  Adenocarcinoma of the ileum in a patient with cystic fibrosis.

Authors:  L E Samuels; G Amrom; M D Kerstein
Journal:  Dig Dis Sci       Date:  1995-01       Impact factor: 3.199

Review 3.  Crohn's disease and cystic fibrosis.

Authors:  J D Lloyd-Still
Journal:  Dig Dis Sci       Date:  1994-04       Impact factor: 3.199

4.  Cancer risk among lung transplant recipients with cystic fibrosis.

Authors:  Aliza K Fink; Elizabeth L Yanik; Bruce C Marshall; Michael Wilschanski; Charles F Lynch; April A Austin; Glenn Copeland; Mahboobeh Safaeian; Eric A Engels
Journal:  J Cyst Fibros       Date:  2016-08-15       Impact factor: 5.527

Review 5.  What Role Does CFTR Play in Development, Differentiation, Regeneration and Cancer?

Authors:  Margarida D Amaral; Margarida C Quaresma; Ines Pankonien
Journal:  Int J Mol Sci       Date:  2020-04-29       Impact factor: 5.923

6.  A cohort study of cystic fibrosis and malignancy.

Authors:  C D Sheldon; M E Hodson; L M Carpenter; A J Swerdlow
Journal:  Br J Cancer       Date:  1993-11       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.